- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
63 Cards in this Set
- Front
- Back
|
what is toxicity
|
ability of an agent to cause injury
|
|
what is risk
|
expected frequency o foccurrence of an undesirable effect
|
|
what is hazard
|
likelihood that injury will occur in any given situation
|
|
what is LD50
|
dose which causes death in 50 percent of exposed animals
|
|
what is a graded dose response relation ship
|
increase in magintude of dose increases magnitude of response
|
|
what is a quantal dose response relationship
|
the percentage of the population affected increases as the dose is raised
|
|
what is ED50
|
dose where 50 percent of subjects show a response
|
|
what is the formula for therapeudic index
|
LD50/ED50
|
|
what are the three types of toxic reactions
|
- pharmacological
- pathological - genotoxic |
|
what is local toxicity
|
toxcicity effect at the site where the toxin first encounters the body with rapid onset and short duration
|
|
what is systemic toxicity
|
involves one or more systems in the body
|
|
what is chemical allergy
|
adverse reaction that results from previous sensitization to a compound or to one that is structurally similar
|
|
what are the rule when evaluating patients
|
treat the patient not the poison
|
|
what is the goal of termination of exposure
|
decrease the dose the patient recieves
|
|
what are the three methods of emeiss
|
- mechanical
- ipecac - apomorphine |
|
what are the 5 methods of prevention of absorption
|
- emesis
- gastric lavage - chemical absorption - chemical inactivation - purgation |
|
what is used for prevention of absorption by chemical absorption
|
activated charcoal
|
|
what are three ways to increase elimination
|
- alter metabolism
- modify urinary excretion - dialysis |
|
what are the two methods to change urinary excretion
|
diuretics
modify urine pH |
|
what drug can cause acifification of the urine
|
amphetamine
|
|
what two drugs can cause alkalinization of urine
|
phenobarbital
salicylates |
|
how do you counter opiod intoxication
|
naloxone
|
|
how do you counter heavy metal poisoning
|
chelating agents
|
|
what is the antidote for acetaminophen OD
|
acetylcystein
|
|
what is the antidotes for anticholinesterase OD
|
atropine
|
|
what is the antidote for antimuscarinic agent OD
|
physostigmine
|
|
what is the antidote for ethylene glycol OD
|
Ethanol
|
|
what is the antidote for arsenic OD
|
dimercaprol (BAL
|
|
what is the antidote for copper OD
|
penicillamine
|
|
what is the antidote for gold OD
|
BAL or penicillamine
|
|
What is the antidote for lead OD
|
calcium disodium edetate (CaEDTA) or penicillamine
|
|
what is the treatment for mercury OD
|
nacetylpenicillamine or BAL
|
|
what is the treatment for iron OD
|
eferoxamine
|
|
what is the treatment for methanolol OD
|
ethanol
|
|
what is the treatment for organophosphate OD
|
atropine + pralidozime (2-PAM
|
|
where are the four places that heavy metals are absorbed
|
- Mainly Gi
- respiratory - mucosal surfaces - skin |
|
where is the distribution of heavy metal in heavy metal toxicity (5)
|
soft tissue
- CNS - Liver - Kidney - skeleton (lead only) |
|
where does metabolism of heavy metals occur
|
liver
|
|
where does exretion of heavy metals occur (4)
|
- kidneys
- sweat - GI - Breast Milk |
|
what is the pharmacodynamics for lead
|
displace cation, espeically calcium in bone
|
|
what is the pharmacodynamics for lead and mercury
|
- alter membrane structure
|
|
what does lead toxicity in children lead to (7)
|
- Developmental delay
- decrease neurocognitive function - hyperkinesis - aggressive behavior - convulsions - peripheral neuropathies - metabolic disorders |
|
what are the hallmark signs for lead poisoning
|
muscle weakness
wrist or foot drop |
|
what are teh CNS effects of lead
|
encephalopathy in all ages
|
|
what are the effects of lead poisioning in adults (5)
|
- GI disturbances
- Milky vomit - abdominal pain - metallic taste - black stools |
|
how does lead OD affect blood
|
hypochromic microcytic anemia due to decreased lifespane
|
|
what does mercury toxicity cause (4)
|
-behavioral problems
- peripheral neuropathy -acture renal tubular necrosis - gastroenteritis |
|
what does arsenic cause (5)
|
- shock
- arrhythmias - peripheral neuropathy encephalopathy - cancer |
|
what is the michaelis menton formula
|
V = (Vmax* [S]) / Km+ [S]
|
|
what are first order reactions according to michaelis menten model
|
- KM is very large relative to substrate con
- drug is elimitated exponentially - conc never reaches zero - non saturable |
|
what does a change in dose in 1st order kinetics cause
|
a change in dose will lead to a proporinonate change in the steady state plasma level achieved
|
|
what is saturation kinetics in micealis menton model
|
- [S] is very large relative to Km
- velocity is capacity limited by VBmax - only a fixed amount of drug can transverse the pathway per unit time |
|
what occurs in saturation kinetics if plasma drug conc exceed vmax
|
further dose increase will result in disproportionate and unexpectedly high plasma drug conc
|
|
what are the three main objects in human drug testing
|
- determine whether the pharmacologic effects seen in humans confirm predictions derived from animal data
- to show that pharmacological actions lead to therapeutically useful effects - to determine safety in humans |
|
what trials must be completed before a drug can be approved
|
phase III
|
|
who monitors adverse reactions of drugs following marketing
|
Committee on safety of medicines
|
|
what is the application called to start testing new drugs in humans
|
investigational new drug application
|
|
what 5 things are included in the IND
|
- information on the compositon and source of drug
- manufacturing information - all data from animal studies - clinical plans and protocols - names and creditial of physicians who will conduct the clinical trials |
|
what must be approved before human clinical trials began
|
- IND
|
|
why do most drugs not reach phase 3 human studies
|
because of toxicity occuring or because the pharmaceutical therapeutic benefit did not occur in humans
|
|
what is the most rigorus and most widley used control clinical trial
|
- concurrent control
|
|
what is a concurrent control study
|
- concurrent control group receivdes the placebo and is observed simultaneously with the group given the experimental drug
- most are double blind, randomized and cross-over design |
|
what occurs in cross over designs
|
- patients act as their own control in that they recieve either the test drug, the standard control drug and the placebo for a certain period
|